Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Mutations (EGFR-m) and Breast Cancer (BC): A Retrospective Analysis

被引：0

作者：

Moran, Teresa ^{[1
]}

Quiroga, Vanesa ^{[1
]}

Carcereny, Enric ^{[1
]}

Cirauqui, Beatriz ^{[1
]}

Margeli, Mireia ^{[1
]}

Vila, Laia ^{[1
]}

De Los, Maria ^{[1
]}

机构：

[1] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

EGFR mutations; Breast Cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MINI13.13

引用

页码：S310 / S311

页数：2

共 50 条

[21] Treatment Strategies for Non-Small Cell Lung Cancer with Common EGFR Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data
Marin-Acevedo, Julian A.
Pellini, Bruna
Kimbrough, ErinMarie O.
Hicks, J. Kevin
Chiappori, Alberto
CANCERS, 2023, 15 (03)
[22] First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations
Kuwako, Tomohito
Imai, Hisao
Masuda, Tomomi
Miura, Yosuke
Seki, Kaori
Yoshino, Reiko
Kaira, Kyoichi
Utsugi, Mitsuyoshi
Shimizu, Kimihiro
Sunaga, Noriaki
Tomizawa, Yoshio
Ishihara, Shinichi
Ishizuka, Takao
Mogi, Akira
Hisada, Takeshi
Minato, Koichi
Takise, Atsushi
Saito, Ryusei
Yamada, Masanobu
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 761 - 769
[23] Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
Yan, Dan
Earp, H. Shelton
DeRyckere, Deborah
Graham, Douglas K.
CANCERS, 2021, 13 (22)
[24] Treatment with EGFR-TKIs in Non Small Cell Lung Cancer Patients. The Impact of EGFR Mutations
Garcia Manrique, Teresa
Carrillo De Albornoz, Rosario
Milena Vargas, Ana
Alamo De la Gala, M. Carmen
Grueso Lopez, Ana Maria
Barros Perez, M. Mar
Vicente Baz, David
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S408 - S408
[25] PREVALENCE OF MUTATIONS IN EGFR, KRAS AND BRAF IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AS ASSESSED BY A PANEL OF PCR-BASED ASSAYS
O'Donnell, Patrick
Current, Robert
Ferguson, Jane
Chien, Shih-Chang
Wen, Wei
Tsan, Alison
Newton, Nick
Jung, Laura
Bauer, Keith
Langland, Rachel
Brophy, Victoria
Schoenbrunner, Nancy
Myers, Thomas
Soviero, Stephen
Lawrence, Jeffrey
Wu, Lin
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1533 - S1534
[26] Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
Anqi Lin
Ting Wei
Hui Meng
Peng Luo
Jian Zhang
Molecular Cancer, 18
[27] Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
Lin, Anqi
Wei, Ting
Meng, Hui
Luo, Peng
Zhang, Jian
MOLECULAR CANCER, 2019, 18 (01)
[28] A Comparison of Methods for EGFR Mutation Testing in Non-Small Cell Lung Cancer
Young, Elizabeth C.
Owens, Martina M.
Adebiyi, Idowu
Bedenham, Tina
Butler, Rachel
Callaway, Jonathan
Cranston, Treena
Crosby, Charlene
Cree, Ian A.
Dutton, Laura
Faulkes, Catherine
Faulkner, Claire
Howard, Emma
Knight, Julia
Huang, Yuanxue
Lavender, Louise
Lazarou, Lazarus P.
Liu, Hongxiang
Mair, Debbie
Milano, Antonio
Sandell, Stacey
Skinner, Alison
Wallace, Andrew
Williams, Maggie
Spivey, Vicky
Goodall, John
Frampton, Jonathan
Ellard, Sian
DIAGNOSTIC MOLECULAR PATHOLOGY, 2013, 22 (04) : 190 - 195
[29] Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
Rafael Rosell
Teresa Morán
Enric Carcereny
Vanessa Quiroga
Miguel Ángel Molina
Carlota Costa
Susana Benlloch
Miquel Tarón
Clinical and Translational Oncology, 2010, 12 : 75 - 80
[30] The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non-Small Cell Lung Cancer-Harboring EGFR Mutations
Li, Hongwei
Wang, Weili
Yang, Xiaotang
Lian, Jianhong
Zhang, Shuangping
Cao, Jianzhong
Zhang, Xiaqin
Song, Xin
Jia, Sufang
Xue, Ruiqi
CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5659 - 5665

← 1 2 3 4 5 →